PVLA
Palvella Therapeutics
PVLA
PVLA
43 hedge funds and large institutions have $12M invested in Palvella Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
12% less funds holding
Funds holding: 49 → 43 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
43
Holding in Top 10
1
Calls
$24K
Puts
$1K
Top Buyers
| 1 | +$112K | |
| 2 | +$67.2K | |
| 3 | +$29.6K | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$29.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$29.2K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$436K | |
| 3 | -$159K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$17.7K |
| 5 |
AC
Annandale Capital
Dallas,
Texas
|
-$10K |